TC Biopharm Holdings PLC-ADRTCBPY
13F holders, Q3 2025 (September 30)1holders −1
0new positions
1sold out
$0.20avg. 13F price*
At the end of Q3 2025, 1 institutions reported holding TC Biopharm Holdings PLC-ADR (TCBPY) in their 13F filings, down 1 from Q2 2025. 0 opened new positions and 1 sold out. The largest holder was Rhumbline Advisers ($1).
- Company
- TC Biopharm Holdings PLC-ADR
- CUSIP
- 87807D608
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $82 |
All 13F filers, Q2 2025 → Q3 2025: 240 shares sold, net −240 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Rhumbline Advisers | 0.00% | Reduce -66.7% | 5 | $1 |
"% of holder's portfolio" is TCBPY's weight in each manager's 13F, not the share of TC Biopharm Holdings PLC-ADR the manager owns.